Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Eisinger

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|July 1, 1979
[Silicon, bone tissue and immunity]A Schiano, F Eisinger, P Detolle, et al.
Bulletin Du Cancer|August 1, 1994
[Attitude of the French female population to cancer screening]F Eisinger, J P Moatti, V Béja, et al.
Psycho-Oncology|December 9, 2008
Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relativesC Cypowyj, F Eisinger, L Huiart, et al.
Community Genetics|August 28, 2004
Information-seeking behaviour and psycho-social interactions during the genetic testing processC Cypowyj, F Eisinger, M Morin, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|July 25, 2008
[Endometrial cancer in HNPCC syndrome]F Lécuru, Y Ansquer, A-S Bats, et al.
International Journal of Oncology|December 15, 2000
Tamoxifen and breast cancer risk in women harboring a BRCA1 germline mutation: computed efficacy, effectiveness and impactF Eisinger, E Charafe-Jauffret, J Jacquemier, et al.
Journal of the National Cancer Institute|May 21, 1997
Acceptable strategies for dealing with hereditary breast/ovarian cancer riskF Eisinger, C J Reynier, F Chabal, et al.
Journal of the National Cancer Institute|August 19, 1999
More about: multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutationsF Eisinger, J Jacquemier, E Charafe-Jauffret, et al.
JAMA|January 14, 2000
Acceptability of prophylactic mastectomy in cancer-prone womenF Eisinger, C Julian-Reynier, H Sobol, et al.
Gastroenterologie Clinique Et Biologique|September 14, 2010
Sociogeographical factors associated with participation in colorectal cancer screeningL Le Retraite, F Eisinger, A Loundou, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|July 1, 1979
[Silicon, bone tissue and immunity]A Schiano, F Eisinger, P Detolle, et al.
Bulletin Du Cancer|August 1, 1994
[Attitude of the French female population to cancer screening]F Eisinger, J P Moatti, V Béja, et al.
Psycho-Oncology|December 9, 2008
Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relativesC Cypowyj, F Eisinger, L Huiart, et al.
Community Genetics|August 28, 2004
Information-seeking behaviour and psycho-social interactions during the genetic testing processC Cypowyj, F Eisinger, M Morin, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|July 25, 2008
[Endometrial cancer in HNPCC syndrome]F Lécuru, Y Ansquer, A-S Bats, et al.
International Journal of Oncology|December 15, 2000
Tamoxifen and breast cancer risk in women harboring a BRCA1 germline mutation: computed efficacy, effectiveness and impactF Eisinger, E Charafe-Jauffret, J Jacquemier, et al.
Journal of the National Cancer Institute|May 21, 1997
Acceptable strategies for dealing with hereditary breast/ovarian cancer riskF Eisinger, C J Reynier, F Chabal, et al.
Journal of the National Cancer Institute|August 19, 1999
More about: multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutationsF Eisinger, J Jacquemier, E Charafe-Jauffret, et al.
JAMA|January 14, 2000
Acceptability of prophylactic mastectomy in cancer-prone womenF Eisinger, C Julian-Reynier, H Sobol, et al.
Gastroenterologie Clinique Et Biologique|September 14, 2010
Sociogeographical factors associated with participation in colorectal cancer screeningL Le Retraite, F Eisinger, A Loundou, et al.
Pageof 10